Detalhe da pesquisa
1.
Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study.
Eur Heart J
; 43(21): 2037-2050, 2022 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35090007
2.
Advancing electrophysiology: partnerships achieve meaningful innovation.
Europace
; 21(Supplement_3): iii29-iii31, 2019 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31400220
3.
Response to cardiac resynchronisation therapy in men and women: a secondary analysis of the SMART-AV randomised controlled trial.
BMJ Open
; 11(10): e049017, 2021 10 27.
Artigo
Inglês
| MEDLINE | ID: mdl-34706949
4.
Device-related infection in de novo transvenous implantable cardioverter-defibrillator Medicare patients.
Heart Rhythm
; 18(8): 1301-1309, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33887452
5.
Association of Implantable Device Measured Physical Activity With Hospitalization for Heart Failure.
JACC Heart Fail
; 8(4): 280-288, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32035894
6.
Impact of Body Mass Index on Safety and Efficacy of the Subcutaneous Implantable Cardioverter-Defibrillator.
JACC Clin Electrophysiol
; 4(5): 652-659, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29798794
7.
Subcutaneous implantable cardioverter-defibrillator Post-Approval Study: Clinical characteristics and perioperative results.
Heart Rhythm
; 14(10): 1456-1463, 2017 10.
Artigo
Inglês
| MEDLINE | ID: mdl-28502872
8.
Performance of the subcutaneous implantable cardioverter-defibrillator in patients with a primary prevention indication with and without a reduced ejection fraction versus patients with a secondary prevention indication.
Heart Rhythm
; 14(3): 367-375, 2017 03.
Artigo
Inglês
| MEDLINE | ID: mdl-27890798
9.
REPLY: Reshaping Patient Outcomes With Machine Learning.
JACC Clin Electrophysiol
; 7(12): 1623-1624, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34949428